Document Detail

Use of polydimethylsiloxane subdermal implants for correcting facial deformities in Down's syndrome.
MedLine Citation:
PMID:  6236296     Owner:  NLM     Status:  MEDLINE    
The use of polydimethylsiloxane prostheses to improve facial appearance in patients with Down's syndrome is reported. In 1 year, 50 patients were treated with 120 prostheses. A follow-up of 8 to 18 months showed that a low incidence of minor complications occurred. Combined with the satisfactory results experienced, this makes the procedure safe and desirable.
S Taicher; M Sela; J Lewin-Epstein; M R Wexler; I J Peled
Related Documents :
25305036 - Quality of life in bile duct injury: 1-, 5-, and 10-year outcomes after surgical repair.
22347716 - A stercoral perforation of the descending colon.
19929336 - Intradural cervical root adjacent interconnections in the normal, prefixed, and postfix...
2968976 - The use of radiofrequency lesions for pain relief in failed back patients.
1127996 - Congenital hypertrophic pyloric stenosis. surgical experience.
22898416 - Resolving external pancreatic fistulas in patients with disconnected pancreatic duct sy...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of prosthetic dentistry     Volume:  52     ISSN:  0022-3913     ISO Abbreviation:  J Prosthet Dent     Publication Date:  1984 Aug 
Date Detail:
Created Date:  1984-10-25     Completed Date:  1984-10-25     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0376364     Medline TA:  J Prosthet Dent     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  264-6     Citation Subset:  D; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Down Syndrome / rehabilitation*
Face / anatomy & histology,  surgery*
Follow-Up Studies
Prostheses and Implants*
Reg. No./Substance:
0/Dimethylpolysiloxanes; 0/Silicones

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Molecular basis for the pharmacological actions of Clostridium botulinum type C2 toxin.
Next Document:  Down's syndrome children and parental psychological upset.